Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success

Europace

Volumn 15, Issue 8, 2013, Pages 1143-1149

  Neumann, Thomas ^a   Wójcik, Maciej ^a,b   Berkowitsch, Alexander ^a   Erkapic, Damir ^a   Zaltsberg, Sergey ^a   Greiss, Harald ^a   Pajitnev, Dimitri ^a   Lehinant, Stefan ^a   Schmitt, Jörn ^a   Hamm, Christian W ^a,c   Pitschner, Heinz F ^a   Kuniss, Malte ^a  

^a Kerckhoff Heart and Thorax Center ^*  (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Ablation; Arrhythmia; Catheter ablation; Cryoballoon; Long term follow up; Paroxysmal atrial fibrillation; Pulmonary vein isolation; Tachyarrhythmias

Indexed keywords

CREATININE;

ADULT; AREA UNDER THE CURVE; ARTERIOVENOUS FISTULA; ARTICLE; BALLOON; CARDIAC PATIENT; CARDIOVASCULAR RISK; CARDIOVERSION; CRYOABLATION; CRYOBALLOON ABLATION; DIABETES MELLITUS; ELECTROCARDIOGRAM; EVENT FREE SURVIVAL; FALSE ANEURYSM; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HEMATOMA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PREDICTION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RETROPERITONEAL HEMORRHAGE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84880938452     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut021     Document Type: Article

References (35)

1. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005;293:2634-40
2. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF Study. J Am Coll Cardiol 2006;48:2340-47
3. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008;118:2498-505
4. Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: A systematic review. Arch Intern Med 2008; 168:581-6
5. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-Analyses. Circ Arrhythm Electrophysiol 2009;2: 349-61
6. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: A meta-Analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2:626-33
7. Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:138-44
8. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet 2012;379:648-61
9. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A et al. ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010;303:333-40
10. Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010;3:615-23
11. Solheim E, Hoff PI, Off MK, Ohm OJ, Chen J. Significance of late recurrence of atrial fibrillation during long-Term follow-Up after pulmonary vein isolation. Pacing Clin Electrophysiol 2007;30(Suppl. 1):S108-11
12. Shah AN, Mittal S, Sichrovsky TC, Cotiga D, Arshad A, Maleki K et al. Long-Term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol 2008;19:661-7
13. Weerasooriya R, Jais P, Le Heuzey JY, Scaveé C, Choi KJ, Macle L et al. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2003;26:292-4
14. Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr CR. Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:907-13
15. Lellouche N, Jais P, Nault I, Wright M, Bevilacqua M, Knecht S et al. Early recurrences after atrial fibrillation ablation: Prognostic value and effect of early reablation. J Cardiovasc Electrophysiol 2008;19:599-605
16. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105: 1077-81
17. Neumann T, Kuniss M, Conradi G, Janin S, Berkowitsch A, Wojcik M et al. MEDAFI-Trial (micro-embolization during ablation of atrial fibrillation): Comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace 2011;13:37-44
18. Dewire J, Calkins H. State-of-The-Art and emerging technologies for atrial fibrillation ablation. Nat Rev Cardiol 2010;7:129-38
19. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/ EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-Up, definitions, endpoints, and research trial design. Europace 2012;14:528-606
20. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ et al. Left atrial size physiologic determinants and clinical applications. J Am Coll Cardiol 2006; 47:2357-63
21. Berkowitsch A, Neumann T, Kuniss M, Janin S, Wojcik M, Zaltsberg S et al. Therapy with renin-Angiotensin system blockers after pulmonary vein isolation in pts with atrial fibrillation: Who is a responder? Pacing Clin Electrophysiol 2010; 33:1101-11
22. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008;52:273-8
23. Van Belle Y, Janse P, Rivero-Ayerza MJ, Thornton AS, Jessurun ER, Theuns D et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: Feasibility, complications, and short-Term outcome. Eur Heart J 2007;28: 2231-7
24. Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies. Heart Rhythm 2011;9:1444-51
25. Kojodjojo P, O'Neill MD, Lim PB, Malcolm-Lawes L, Whinnett ZI, Salukhe TV et al. Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: Medium-Term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation. Heart 2010;96:1379-84
26. Kühne M, Schaer B, Ammann P, Suter Y, Osswald S, Sticherling C. Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Swiss Med Wkly 2010;140:214-21
27. Packer DL, Irwin JM, Champagne J. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: First results of the North American Arctic Front STOP-AF pivotal trial. J Am Coll Cardiol 2010;55:E3015-16
28. Van Belle Y, Janse P, Theuns D, Szili-Torok T, Jordaens L. One year follow-Up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace 2008;10:1271-6
29. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F et al. Long-Term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008;1: 269-75
30. Fiala M, Chovancík J, Nevralová R, Neuwirth R, Jiravský O, Nykl I et al. Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: Over 3-year results of a prospective randomized study. J Interv Card Electrophysiol 2008;22:13-2132
31. Bertaglia E, Tondo C, De Simone A, Zoppo F, Mantica M, Turco P et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: A 6-year multicentre experience. Europace 2010;12:181-7
32. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T et al. Long-Term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-Up. Circulation 2010;122:2368-77
33. Namdar M, Chierchia GB, Westra S, Sorgente A, Meir ML, Bayrak F et al. Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon. Europace. 2012;14: 197-203
34. Nyrnes A, Mathiesen EB, Njolstad I, Wilsgaard T, Lochen ML. Palpitations are predictive of future atrial fibrillation. An 11-year follow-Up of 22 815 men and women: The Tromso Study. Eur J Prev Cardiol 2012 May 15 [Epub ahead of print] DOI:.
35. Charitos EI, Stierle U, Ziegler PD, Baldewig M, Robinson DR, Sievers HH et al. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: Insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation 2012; 126:806-14